Antihypertensives in Pregnancy

Anna E. Denoble; Sarah A. Goldstein; Christian M. Pettker

doi:10.1016/j.ogc.2022.10.008

Back

Journal article

Peer reviewed

Antihypertensives in Pregnancy

Anna E. Denoble, Sarah A. Goldstein and Christian M. Pettker

Obstetrics and gynecology clinics of North America, Vol.50(1), pp.39-78

03/01/2023

DOI: 10.1016/j.ogc.2022.10.008

PMID: 36822710

View Online

Abstract

Hypertensive disorders of pregnancy (HDP) can result in significant maternal morbidity and even mortality. Available data suggest that many antihypertensives can be safely used in pregnant patients, albeit with close supervision of parameters like fetal growth and amniotic fluid volume. This article summarizes current guidelines on the diagnosis and treatment of hypertension in pregnancy and provides an in-depth guide to the available safety and efficacy data for antihypertensives during pregnancy and postpartum.

American College of Cardiology

American College of Obstetricians and Gynecologists

American Heart Association

Antihypertensive

Chronic hypertension

Gestational hypertension

Pharmacokinetics in pregnancy

Preeclampsia

Details

Title: Subtitle: Antihypertensives in Pregnancy
Creators: Anna E. Denoble - Yale University
Sarah A. Goldstein - Yale University
Christian M. Pettker - Yale University
Resource Type: Journal article
Publication Details: Obstetrics and gynecology clinics of North America, Vol.50(1), pp.39-78
DOI: 10.1016/j.ogc.2022.10.008
PMID: 36822710
NLM abbreviation: Obstet Gynecol Clin North Am
ISSN: 0889-8545
eISSN: 1558-0474
Publisher: Elsevier Inc
Number of pages: 40
Language: English
Date published: 03/01/2023
Academic Unit: Obstetrics and Gynecology
Record Identifier: 9985244537902771

Metrics

4 Record Views

1 Times Cited - Web of Science